Sign in to fuzzto save your conversations, follow your research and come back anytime.
Meghmani Organics
MOL
NSE
BSE
NSEBSESectorChemicals
67.52
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Meghmani Organics posts a sharp earnings rebound in Q1 FY27, reversing a mid-year profit slump through improved margins and disciplined cost management.
Consolidated EBITDA margin expanded from 4.2% in Q4 FY26 to 18.0% in Q1 FY27, confirming strong pricing power.
Share price fell from ₹98.97 in Q1 FY26 to ₹36.74 in Q4 FY26, reflecting sustained investor caution.
Consolidated PAT recovered from a loss of ₹3.5 Cr in Q3 FY26 to ₹48.2 Cr in Q1 FY27, marking a clear earnings turnaround.
Free float market cap compressed from ₹1,284 Cr in Q1 FY26 to ₹477 Cr in Q4 FY26, signaling valuation pressure.
Finance costs declined from ₹29.5 Cr in Q1 FY26 to ₹13.1 Cr in Q1 FY27, reflecting steady debt reduction.
Pigments capacity utilisation dropped from 46% in Q1 FY26 to 30% in Q4 FY26 before recovering to 39% in Q1 FY27, indicating uneven demand.
Crop Protection EBITDA margin climbed from 9.0% in Q4 FY26 to 19.9% in Q1 FY27, driving the segment’s profit recovery.
Trading value fell from ₹9.9 Cr in Q1 FY26 to ₹3.4 Cr in Q4 FY26, highlighting subdued market participation.
Gross margin improved from 36.4% in Q4 FY26 to 46.6% in Q1 FY27, demonstrating a favorable product mix.
Pigments exports percentage fell from 86% in Q1 FY26 to 66% in Q4 FY26 before rising to 70% in Q1 FY27, showing stabilizing foreign sales.
